Abstract
Egg donation was first introduced as a treatment for infertility in 1983, with its popularity steadily increasing over the past three decades. In the USA, egg donation accounted for approximately 10 % of all assisted reproductive therapies in 2009 compared to 8 % in 2000. In 2009, nearly 15,000 transfers (both fresh and frozen combined) were performed using donated eggs.
Because uterine receptivity appears to be unchanged as a woman ages, pregnancy occurs in greater than 50 % of embryo transfers using donated eggs in the setting of a hormonally prepared uterine lining. This pregnancy rate is remarkable since most recipients are often older and typically would not be capable of conceiving with their own eggs. According to the 2009 Centers for Disease Control (CDC) data, the majority of recipients are older than 40 years of age. Because egg donors are women at the “peak” of their fertility potential, aged 21–32 years old, the percentage of live births from anonymous donated eggs is >50 % regardless of the age of the recipient.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blakeslee S. Infertile woman has baby through embryo transfer. New York Times. 4 Feb 1984.
SART. Clinic summary report 2009. www.sart.org.
CDC, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology, and RESOLVE. 2000 assisted reproductive technology success rates. Atlanta: US Department of Health and Human Services, CDC; 2002.
Sauer MV. The impact of age on reproductive potential: lessons learned from oocyte donation. Maturitas. 1998;30(2):221–5.
Sauer MV, Paulson RJ, Lobo RA. Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA. 1992;268(10):1275–9.
Davis OK, Rosenwaks Z. Preparation of the endometrium for oocyte donation. J Assist Reprod Genet. 1993;10(7):457–9.
Bustillo M, Buster JE, Cohen SW, Hamilton F, Thorneycroft IH, Simon JA, Rodi IA, Boyers SP, Marshall JR, Louw JA, Seed RW, Seed RG. Delivery of a healthy infant following nonsurgical ovum transfer. JAMA. 1984;251(7):889.
Finger R, Sommerfelt C, Freeman M, Wilson CK, Wade A, Daly D. A cost-effectiveness comparison of embryo donation with oocyte donation. Fertil Steril. 2009;93(2):379–81.
Rosenwaks Z, Davis OK, Damario MA. The role of maternal age in assisted reproduction. Hum Reprod. 1995;10 Suppl 1:165–73.
Hoffman DI, Zellman GL, Fair CC, Mayer JF, Zeitz JG, Gibbons WE, Turner Jr TG. Society for Assisted Reproduction Technology (SART) and RAND. Cryopreserved embryos in the United States and their availability for research. Fertil Steril. 2003;79(5):1063–9.
Morris RS, Sauer MV. New advances in the treatment of infertility in women with ovarian failure. Curr Opin Obstet Gynecol. 1993;5(3):368–77.
Paulson RJ, et al. Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age. JAMA. 2002;288(18):2320–3.
Chevalier N, et al. Materno-fetal cardiovascular complications in turner syndrome after oocyte donation: insufficient prepregnancy screening and pregnancy follow-up are associated with poor outcome. J Clin Endocrinol Metab. 2011;96(2):E260–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Dayal, M.B. (2013). Indications for Egg and Embryo Donation. In: Sauer, M. (eds) Principles of Oocyte and Embryo Donation. Springer, London. https://doi.org/10.1007/978-1-4471-2392-7_2
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2392-7_2
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2391-0
Online ISBN: 978-1-4471-2392-7
eBook Packages: MedicineMedicine (R0)